Anne-Marie Lefebvre

Years Active: 2020-2022
Publications (10 Years): 2

Sanofi-Aventis Recherche Developpement Chilly-Mazarin Longjumeau

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Sanofi-Aventis Recherche Developpement Chilly-Mazarin Longjumeau Jul 01 2001

France

Lab Head

Publications

Maria Francesca Evaristi, Bruno Poirier, Xavier Chénedé, Anne-Marie Lefebvre, Alain Roccon, Florence Gillot, Sandra Beeské, Alain Corbier, Marie-Pierre Pruniaux-Harnist, Philip Janiak, Ashfaq A Parkar
A G-protein-biased S1P1 agonist, SAR247799, improved LVH and diastolic function in a rat model of metabolic syndrome. PloS one 17 (1) (2022)
Stéphanie Decary, Pierre-François Berne, Céline Nicolazzi, Anne-Marie Lefebvre, Tarik Dabdoubi, Béatrice Cameron, Pierrick Rival, Catherine Devaud, Catherine Prades, Hervé Bouchard, Alhassan Cassé, Christophe Henry, Céline Amara, Claire Brillac, Paul Ferrari, Laetitia Maçon, Eric Lacoste, Cecile Combeau, Eric Beys, Souad Naimi, Carlos García-Echeverría, Jean-François Mayaux, Véronique Blanc
Preclinical Activity of SAR408701: A Novel Anti-CEACAM5-maytansinoid Antibody-drug Conjugate for the Treatment of CEACAM5-positive Epithelial Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (24) (2020)

Anne-Marie Lefebvre.css-eqlu8i{font-size:small;padding-left:4px;}